Generex Biotechnology Corp. | Income Statement
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
463.70
368.40
380.70
265.20
5.00
-
Gross Income
463.70
368.40
380.70
265.20
5.00
-
SG&A Expense
5,665.60
4,031.20
3,182.20
1,637.40
1,591.80
3,174.50
EBIT
6,129.40
4,399.70
3,562.90
1,902.60
1,596.80
2,495.60
Unusual Expense
3,140.30
4,525.70
1,719.60
902.00
74,492.70
39,027.90
Non Operating Income/Expense
1,245.20
193.60
-
-
-
-
Interest Expense
530.20
321.70
350.00
418.50
743.10
583.60
Pretax Income
8,554.30
1.40
2,193.40
3,223.10
76,832.60
35,948.70
Consolidated Net Income
8,554.30
1.40
2,193.40
3,223.10
76,832.60
35,948.70
Net Income
8,554.30
1.40
2,193.40
3,223.10
70,016.20
36,334.10
Net Income After Extraordinaries
8,554.30
1.40
2,193.40
3,223.10
70,016.20
36,334.10
Net Income Available to Common
10,276.80
2,059.70
2,532.90
3,223.10
70,016.20
36,334.10
EPS (Basic)
20.00
3.03
3.19
4.00
70.92
0.67
Basic Shares Outstanding
443.60
679.60
793.30
880.90
987.30
22,430.10
EPS (Diluted)
23.17
3.03
3.19
3.66
70.92
0.67
Diluted Shares Outstanding
443.60
679.60
793.30
880.90
987.30
54,413.80
EBITDA
5,665.60
4,031.20
3,182.20
1,637.40
1,591.80
2,471.30
Non-Operating Interest Income
0.40
0.60
0.00
-
-
-
Minority Interest Expense
-
-
-
-
6,816.40
385.40
Preferred Dividends
1,722.50
2,058.30
339.60
-
-
-
About Generex Biotechnology
View Profile
